img

Global Bladder Cancer Targeted Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bladder Cancer Targeted Drug Market Research Report 2024

Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. This type of treatment blocks the growth and spread of cancer cells and tries to limit damage to healthy cells.
According to Mr Accuracy reports new survey, global Bladder Cancer Targeted Drug market is projected to reach US$ 1414.2 million in 2029, increasing from US$ 758 million in 2022, with the CAGR of 9.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bladder Cancer Targeted Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bladder Cancer Targeted Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Merck KGaA
Roche
Astellas
Janssen Biotech
Bristol-Myers Squibb
Merck & Co.
Gilead Sciences
Segment by Type
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Erdafitinib (Balversa)
Other

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Bladder Cancer Targeted Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bladder Cancer Targeted Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Atezolizumab (Tecentriq)
1.2.3 Avelumab (Bavencio)
1.2.4 Erdafitinib (Balversa)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Bladder Cancer Targeted Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bladder Cancer Targeted Drug Market Perspective (2018-2029)
2.2 Bladder Cancer Targeted Drug Growth Trends by Region
2.2.1 Global Bladder Cancer Targeted Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bladder Cancer Targeted Drug Historic Market Size by Region (2018-2024)
2.2.3 Bladder Cancer Targeted Drug Forecasted Market Size by Region (2024-2029)
2.3 Bladder Cancer Targeted Drug Market Dynamics
2.3.1 Bladder Cancer Targeted Drug Industry Trends
2.3.2 Bladder Cancer Targeted Drug Market Drivers
2.3.3 Bladder Cancer Targeted Drug Market Challenges
2.3.4 Bladder Cancer Targeted Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bladder Cancer Targeted Drug Players by Revenue
3.1.1 Global Top Bladder Cancer Targeted Drug Players by Revenue (2018-2024)
3.1.2 Global Bladder Cancer Targeted Drug Revenue Market Share by Players (2018-2024)
3.2 Global Bladder Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bladder Cancer Targeted Drug Revenue
3.4 Global Bladder Cancer Targeted Drug Market Concentration Ratio
3.4.1 Global Bladder Cancer Targeted Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Targeted Drug Revenue in 2022
3.5 Bladder Cancer Targeted Drug Key Players Head office and Area Served
3.6 Key Players Bladder Cancer Targeted Drug Product Solution and Service
3.7 Date of Enter into Bladder Cancer Targeted Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bladder Cancer Targeted Drug Breakdown Data by Type
4.1 Global Bladder Cancer Targeted Drug Historic Market Size by Type (2018-2024)
4.2 Global Bladder Cancer Targeted Drug Forecasted Market Size by Type (2024-2029)
5 Bladder Cancer Targeted Drug Breakdown Data by Application
5.1 Global Bladder Cancer Targeted Drug Historic Market Size by Application (2018-2024)
5.2 Global Bladder Cancer Targeted Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bladder Cancer Targeted Drug Market Size (2018-2029)
6.2 North America Bladder Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bladder Cancer Targeted Drug Market Size by Country (2018-2024)
6.4 North America Bladder Cancer Targeted Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bladder Cancer Targeted Drug Market Size (2018-2029)
7.2 Europe Bladder Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bladder Cancer Targeted Drug Market Size by Country (2018-2024)
7.4 Europe Bladder Cancer Targeted Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bladder Cancer Targeted Drug Market Size (2018-2029)
8.2 Asia-Pacific Bladder Cancer Targeted Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bladder Cancer Targeted Drug Market Size (2018-2029)
9.2 Latin America Bladder Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bladder Cancer Targeted Drug Market Size by Country (2018-2024)
9.4 Latin America Bladder Cancer Targeted Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bladder Cancer Targeted Drug Market Size (2018-2029)
10.2 Middle East & Africa Bladder Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Bladder Cancer Targeted Drug Introduction
11.1.4 Pfizer Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Bladder Cancer Targeted Drug Introduction
11.2.4 Merck KGaA Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.2.5 Merck KGaA Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Bladder Cancer Targeted Drug Introduction
11.3.4 Roche Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.3.5 Roche Recent Development
11.4 Astellas
11.4.1 Astellas Company Detail
11.4.2 Astellas Business Overview
11.4.3 Astellas Bladder Cancer Targeted Drug Introduction
11.4.4 Astellas Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.4.5 Astellas Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Bladder Cancer Targeted Drug Introduction
11.5.4 Janssen Biotech Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.5.5 Janssen Biotech Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Bladder Cancer Targeted Drug Introduction
11.6.4 Bristol-Myers Squibb Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Detail
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Bladder Cancer Targeted Drug Introduction
11.7.4 Merck & Co. Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.7.5 Merck & Co. Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Bladder Cancer Targeted Drug Introduction
11.8.4 Gilead Sciences Revenue in Bladder Cancer Targeted Drug Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Bladder Cancer Targeted Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Atezolizumab (Tecentriq)
Table 3. Key Players of Avelumab (Bavencio)
Table 4. Key Players of Erdafitinib (Balversa)
Table 5. Key Players of Other
Table 6. Global Bladder Cancer Targeted Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Bladder Cancer Targeted Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Bladder Cancer Targeted Drug Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Bladder Cancer Targeted Drug Market Share by Region (2018-2024)
Table 10. Global Bladder Cancer Targeted Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Bladder Cancer Targeted Drug Market Share by Region (2024-2029)
Table 12. Bladder Cancer Targeted Drug Market Trends
Table 13. Bladder Cancer Targeted Drug Market Drivers
Table 14. Bladder Cancer Targeted Drug Market Challenges
Table 15. Bladder Cancer Targeted Drug Market Restraints
Table 16. Global Bladder Cancer Targeted Drug Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Bladder Cancer Targeted Drug Market Share by Players (2018-2024)
Table 18. Global Top Bladder Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer Targeted Drug as of 2022)
Table 19. Ranking of Global Top Bladder Cancer Targeted Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Bladder Cancer Targeted Drug Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bladder Cancer Targeted Drug Product Solution and Service
Table 23. Date of Enter into Bladder Cancer Targeted Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bladder Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Bladder Cancer Targeted Drug Revenue Market Share by Type (2018-2024)
Table 27. Global Bladder Cancer Targeted Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Bladder Cancer Targeted Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Bladder Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Bladder Cancer Targeted Drug Revenue Market Share by Application (2018-2024)
Table 31. Global Bladder Cancer Targeted Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Bladder Cancer Targeted Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Bladder Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Bladder Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Bladder Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Bladder Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Bladder Cancer Targeted Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Bladder Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Bladder Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Bladder Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Bladder Cancer Targeted Drug Product
Table 51. Pfizer Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Merck KGaA Company Detail
Table 54. Merck KGaA Business Overview
Table 55. Merck KGaA Bladder Cancer Targeted Drug Product
Table 56. Merck KGaA Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 57. Merck KGaA Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Bladder Cancer Targeted Drug Product
Table 61. Roche Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Astellas Company Detail
Table 64. Astellas Business Overview
Table 65. Astellas Bladder Cancer Targeted Drug Product
Table 66. Astellas Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 67. Astellas Recent Development
Table 68. Janssen Biotech Company Detail
Table 69. Janssen Biotech Business Overview
Table 70. Janssen Biotech Bladder Cancer Targeted Drug Product
Table 71. Janssen Biotech Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 72. Janssen Biotech Recent Development
Table 73. Bristol-Myers Squibb Company Detail
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Bladder Cancer Targeted Drug Product
Table 76. Bristol-Myers Squibb Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Merck & Co. Company Detail
Table 79. Merck & Co. Business Overview
Table 80. Merck & Co. Bladder Cancer Targeted Drug Product
Table 81. Merck & Co. Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 82. Merck & Co. Recent Development
Table 83. Gilead Sciences Company Detail
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Bladder Cancer Targeted Drug Product
Table 86. Gilead Sciences Revenue in Bladder Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 87. Gilead Sciences Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bladder Cancer Targeted Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Bladder Cancer Targeted Drug Market Share by Type: 2022 VS 2029
Figure 3. Atezolizumab (Tecentriq) Features
Figure 4. Avelumab (Bavencio) Features
Figure 5. Erdafitinib (Balversa) Features
Figure 6. Other Features
Figure 7. Global Bladder Cancer Targeted Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Bladder Cancer Targeted Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Bladder Cancer Targeted Drug Report Years Considered
Figure 13. Global Bladder Cancer Targeted Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Bladder Cancer Targeted Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Bladder Cancer Targeted Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Bladder Cancer Targeted Drug Market Share by Players in 2022
Figure 17. Global Top Bladder Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bladder Cancer Targeted Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Bladder Cancer Targeted Drug Revenue in 2022
Figure 19. North America Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Bladder Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 21. United States Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Bladder Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 25. Germany Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Bladder Cancer Targeted Drug Market Share by Region (2018-2029)
Figure 33. China Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Bladder Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 41. Mexico Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Bladder Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 45. Turkey Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Bladder Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 48. Merck KGaA Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 49. Roche Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 50. Astellas Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 51. Janssen Biotech Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 53. Merck & Co. Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Bladder Cancer Targeted Drug Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries